Activecare Inc. (fka ACARQ)

[scm21st]

The Case for ActiveCare (ACAR)...

How often do we see microcap stocks, penny stocks, whatever you want to call them, take it to the next level and become successful big companies that end up trading over $5 on the NYSE? Not often.

However, ACAR has the potential to reach that lofty goal in a few years. I also think they will end up trading north of $1 per share this year, up from it's current .12, a 52 week low. The case for ACAR follows.

1. New leadership is key - In October of 2011 ActiveCare brought in 2009 Ernst and Young Entrepreneur of the Year winner for Health Care David S. Boone as the new CEO. - http://biz.yahoo.com/e/111017/acar.ob8-k.html

David Boone has a proven track record in the industry and is, in my opinion, the most important piece of the puzzle in the turn around we are about to witness. I encourage you to look into his track record.

2. ActiveCare secures 10 million in Funding - Also in October of last year ActiveCare secured a 10 million dollar line of credit from a consortium of European investors led by Sapinda, Ltd. You don't get that kind of funding without solid evidence of your potential, period. - http://activecare.com/node/122

3. March 20th, ActiveCare acquires 4G Biometrics - The was an excellent acquisition with immediate impact. The merger between 4G Biometrics and ActiveCare instantly added 1,300 members under contract to ACAR's revenue stream. - http://ih.advfn.com/p.php?pid=nmona&article=51697062

4. Institutional Investors now getting in -

March 22nd, Harborview Master Fund - http://ih.advfn.com/p.php?pid=nmona&article=51729614

March 26th, Gemini Strategies, LLC - http://ih.advfn.com/p.php?pid=nmona&article=51774544

Look at their chart and consider the typical time frame required for new leadership to right the ship in a company of this size. The time is now to get in on ACAR, as HarborView and Gemini's investments can attest.